Kimberly represents children with birth defects allegedly caused by antidepressants, including Zoloft®, Effexor® and Wellbutrin®; as well as Zofran® which is used to prevent pregnancy-related nausea and vomiting. She previously litigated against GlaxoSmithKline in the Paxil® birth defect litigation. She serves as co-lead counsel for In re Zofran (Ondansetron) Products Liability Litigation MDL 2657 and is on the Plaintiffs’ Executive Committee for In re Viagra (Sildenafil Citrate) Products Liability Litigation MDL 2691 and on the Plaintiffs’ Steering Committee In re Zoloft (sertraline hydrochloride) Products Liability Litigation MDL 2342. She also manages the firm's pharmaceutical litigation regarding Crestor®, Lipitor®, Actos®, Risperdal®, Incretin Mimetics, and dialysis products GranuFlo® Powder and NaturaLyte® Liquid acid concentrates.
Kimberly also represents elderly victims of abuse and neglect, litigating cases for nursing home and assisted living facility residents.
Kimberly has spoken at numerous seminars, legal gatherings, CLEs and conferences across the U.S., including the American Association for Justice, Mass Torts Made Perfect and the National Business Institute. She has addressed a broad range of topics related to pharmaceutical drugs and elder law litigation, focusing on MDL procedures, birth defects, nursing home litigation, discovery, trial strategy and mediation. Kimberly is currently the Treasurer of the American Association for Justice’s Section on Toxic, Environmental and Pharmaceutical Torts.
Prior to joining Motley Rice, Kimberly worked on the Fen-Phen diet drug litigation and served as an attorney with the California District Attorney's Office in San Diego. Kimberly is recognized as an AV® rated attorney by Martindale-Hubbell®.